Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

6 Months Ended

Jun. 30, 2014

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):

	Three Months Ended June 30,						Six Months Ended June 30,
	2014			2013			2014			2013
Numerator:
Net loss - basic	$	(766	)	$	(12,788	)	$	(7,875	)	$	(22,002	)
Less: noncash income from change in fair value of common stock warrants		(6,665	)		—			(8,122	)		—

Net loss - diluted		(7,431	)		(12,788	)		(15,997	)		(22,002	)

Denominator:
Weighted average common shares outstanding		59,347			57,037			59,325			56,763
Dilutive effect of warrants		3,651			—			4,108			—

Weighted-average common shares outstanding and dilutive potential common shares — diluted		62,998			57,037			63,433			56,763

Net income (loss) per share
Basic	$	(0.01	)	$	(0.22	)	$	(0.13	)	$	(0.39	)
Diluted	$	(0.12	)	$	(0.22	)	$	(0.25	)	$	(0.39	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2014		2013		2014		2013
Shares issuable upon exercise of warrants		—		9,634		—		9,634
Shares issuable upon exercise of stock options		8,161		6,570		8,161		6,570
Shares issuable related to the ESPP		71		85		71		85